We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
(+10%)
Cap. Flow
+$29.6M
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$5.37M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.54M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$2.12M |
| 5 |
NVIDIA
NVDA
|
+$1.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$4.62M |
| 3 |
Oaktree Specialty Lending
OCSL
|
+$825K |
| 4 |
MGI
MoneyGram International, Inc. New
MGI
|
+$627K |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$562K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.18% |
| 2 | Technology | 15.3% |
| 3 | Healthcare | 6.27% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Industrials | 3.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
CarGurus
CARG
$3.32B
| $10.2K | ﹤0.01% |
452
-13
| -3% | -$246 |
|
1452
BioMarin Pharmaceuticals
BMRN
$13.2B
| $10.2K | ﹤0.01% |
118
+1
| +0.9% | +$94 |
|
1453
Ultrapar
UGP
$6.47B
| $10.2K | ﹤0.01% |
2,602
+1,164
| +81% | +$3.83K |
|
1454
Kornit Digital
KRNT
$779M
| $10.2K | ﹤0.01% |
348
+224
| +181% | +$5.06K |
|
1455
Pentair
PNR
$10.7B
| $10.2K | ﹤0.01% |
158
| – | – |
|
|
ALE
1456
DELISTED
Allete
ALE
| $10.2K | ﹤0.01% |
176
-9
| -5% | -$556 |
|
1457
Columbia Sportswear
COLM
$2.92B
| $10.2K | ﹤0.01% |
132
-36
| -21% | -$2.9K |
|
1458
Ultragenyx Pharmaceutical
RARE
$2.64B
| $10.1K | ﹤0.01% |
220
+28
| +15% | +$1.3K |
|
1459
Unitil
UTL
$966M
| $10.1K | ﹤0.01% |
200
+12
| +6% | +$666 |
|
1460
First Mid Bancshares
FMBH
$1.35B
| $10.1K | ﹤0.01% |
419
-931
| -69% | -$23.2K |
|
1461
Primerica
PRI
$9.69B
| $10.1K | ﹤0.01% |
51
-1
| -2% | -$184 |
|
1462
Insmed
INSM
$29.4B
| $10.1K | ﹤0.01% |
477
+160
| +50% | +$3.04K |
|
1463
Nu Skin
NUS
$255M
| $10.1K | ﹤0.01% |
303
-17
| -5% | -$626 |
|
1464
Cytokinetics
CYTK
$10.4B
| $10K | ﹤0.01% |
308
+50
| +19% | +$1.85K |
|
|
CMRC
1465
Commerce.com Inc Series 1
CMRC
$176M
| $10K | ﹤0.01% |
1,007
+671
| +200% | +$5.59K |
|
|
SNBR
1466
DELISTED
Sleep Number
SNBR
| $10K | ﹤0.01% |
367
+85
| +30% | +$1.94K |
|
1467
Saic
SAIC
$5.35B
| $10K | ﹤0.01% |
89
+3
| +3% | +$312 |
|
1468
Diodes
DIOD
$4.68B
| $9.99K | ﹤0.01% |
108
-18
| -14% | -$1.59K |
|
|
AAMI
1469
Acadian Asset Management
AAMI
$3.22B
| $9.97K | ﹤0.01% |
476
| – | – |
|
1470
Medifast
MED
$136M
| $9.95K | ﹤0.01% |
108
+90
| +500% | +$8.01K |
|
1471
TransAlta
TAC
$3.88B
| $9.93K | ﹤0.01% |
1,061
| – | – |
|
1472
Lumentum
LITE
$64.3B
| $9.93K | ﹤0.01% |
175
+69
| +65% | +$3.45K |
|
1473
iShares 7-10 Year Treasury Bond ETF
IEF
$47.1B
| $9.88K | ﹤0.01% |
102
| – | – |
|
|
QVCGA
1474
DELISTED
QVC Group Inc Series A
QVCGA
| $9.87K | ﹤0.01% |
199
-1
| -0.5% | -$45 |
|
1475
Puma Biotechnology
PBYI
$450M
| $9.86K | ﹤0.01% |
2,793
| – | – |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.
- Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
- Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
- Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
- Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
- Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
- Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
- Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.
Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.